Agentix (AGTX) Capital Expenditures (2013)

Agentix's (AGTX) quarterly Capital Expenditures came in at $1328.0 in Q4 2013.

Agentix (AGTX) Capital Expenditures (2013) Analysis & Trends

Agentix (AGTX) has 1 years of Capital Expenditures data on file, last reported at $1328.0 in Q4 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capex (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	112.20 Mn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	240.20 Mn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	37.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	25.02 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	34.68 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	6.26 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	251.02 Mn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-73.57 Mn
10	Agentix	801,339.00	801,301.00	-	-

Download Data

Date	Value
Nov 30, 2013	1,328.00
Nov 30, 2013	1,328.00